Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss
NUCs continuation is not associated with a lower risk of HBsAg seroreversion in patients with serum HBsAg loss following PEG-IFN-based therapy.
Authors
- Bingliang Lin (ORCID: https://orcid.org/0000-0003-4069-6287)
- Zhiliang Gao (ORCID: https://orcid.org/0000-0001-7611-4416)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-1759-1041)
- Qiyi Zhao (ORCID: https://orcid.org/0000-0003-0649-0437)
- Nan Zhang (ORCID: https://orcid.org/0000-0002-8097-6876)
- Haishi Wu (ORCID: https://orcid.org/0009-0000-1446-0313)
- Bin Li (ORCID: https://orcid.org/0000-0002-7393-2111)
- Lili Wu (ORCID: https://orcid.org/0000-0003-3773-2179)
- Na Gao (ORCID: https://orcid.org/0000-0002-8622-9273)
- Huiying Yu (ORCID: https://orcid.org/0009-0007-8113-1289)
Institutions
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- Virology Journal
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1186/s12985-025-02700-2
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Innovative Research Group Project of the National Natural Science Foundation of China
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- Guangzhou Science and Technology Program key projects
- Guangzhou Municipal Science and Technology Project
- Fundamental Research Funds for the Central Universities
- Basic and Applied Basic Research Foundation of Guangdong Province